Tumor endothelial cell-derived Sfrp1 supports the maintenance of cancer stem cells via Wnt signaling
2024
Sfrp1 Supports Cancer Stem Cells in Tumors
Sample size: 14
publication
10 minutes
Evidence: moderate
Author Information
Author(s): Hayashi Yumiko, Hashimoto Masakazu, Takaoka Katsuyoshi, Takemoto Tatsuya, Takakura Nobuyuki
Primary Institution: Fukui University
Hypothesis
Does Sfrp1 play a role in maintaining cancer stem cells through Wnt signaling?
Conclusion
Sfrp1 is crucial for tumor growth by maintaining cancer stem cells via Wnt signaling.
Supporting Evidence
- Sfrp1 is expressed in a subset of tumor endothelial cells.
- Sfrp1 knockout mice showed reduced tumor growth compared to wild-type mice.
- CSCs were maintained in the early tumor growth phase but decreased in the late phase in Sfrp1 KO mice.
- Expression of Wnt signaling target genes decreased significantly in Sfrp1 KO mice during late tumor growth.
Takeaway
Sfrp1 is like a helper for cancer cells, making sure they can grow and survive by keeping special cells called cancer stem cells alive.
Methodology
The study used Sfrp1 knockout mice and flow cytometry to analyze cancer stem cell maintenance and tumor growth.
Limitations
The study did not explore the early stages of angiogenesis or the effects of Sfrp1 on tumor vascular structure.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website